Xoma Series B Preferred Stock (XOMAO)

XOMAO was delisted on the 13th of July, 2026.

• Sector: Healthcare
• Industry: Biotechnology

About: XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates. The Company's drug royalty aggregator business is mainly focused on the acquisition of early to mid-stage clinical assets. Geographically, the company operates in Switzerland, the United States, Asia Pacific, Europe, and other regions.

Employees: 14